Maipu Medical announced that the company's R&D project “Absorbable Hemostatic Fluid Gelatin” has recently officially entered the clinical trial stage. It is registered and classified as a Class III medical device for surgical assisted hemostasis; after the clinical trial is completed, the company will carry out registration and subsequent industrialization and marketing and sales work.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.